{"url_path":"/sec/bkyi/8-k/2026-03-31/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 **         **Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-31","source_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-010506-index.html","accession_number":"0001437749-26-010506","cik":"0001019034","ticker":"BKYI","issuer_name":"BIO KEY INTERNATIONAL INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-010506-index.html","primary_entity_key":"0001019034","primary_entity_name":"BIO KEY INTERNATIONAL INC"},"word_count":127,"has_tables":true,"body_markdown":"**Item 2.02.**         **Results of Operations and Financial Condition.**\n\n \n\nOn March 31,2026, BIO-key International, Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and year ending December 31, 2025. A copy of the press release issued by the Company on March 31, 2026, is attached as Exhibit 99.\n\n \n\nThe information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing."}